BSX
NYSEHealthcareLoading…
Boston Scientific Corporation Common Stock
Sector: Healthcare•United States•Market Cap: $103.5B
Related News
Latest stories connected to BSX
10/78More news →
- RS 49Here's Why Boston Scientific (BSX) Fell More Than Broader MarketZacks Investment Research•16h ago•Original source
- RS 49Stock Market Today, March 30: Boston Scientific Falls After Delivering Underwhelming Trial ResultsThe Motley Fool•17h ago•Original source
- RS 49Boston Scientific Drops Despite Encouraging Trial ReadoutsBenzinga•22h ago•Original source
- RS 49Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitPRNewsWire•3d ago•Original source
- RS 49BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law FirmGlobeNewsWire•4d ago•Original source
- RS 49BSX INVESTOR ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026Newsfile Corp•4d ago•Original source
- RS 49BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud LawsuitPRNewsWire•4d ago•Original source
Financials
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Revenue | 20.07B | 16.75B | 14.24B | 12.68B | 11.89B | 9.91B | 10.73B | 9.82B | 9.05B | 8.39B |
| Cost of Revenue | 6.22B | 6.48B | 5.41B | 4.97B | 4.43B | 4.34B | 3.86B | 3.35B | 3.18B | 3.04B |
| Gross Profit | 13.85B | 10.27B | 8.83B | 7.71B | 7.46B | 5.58B | 6.88B | 6.48B | 5.87B | 5.34B |
| Research and Development Expenses | 2.05B | 1.61B | 1.41B | 1.32B | 1.20B | 1.14B | 1.17B | 1.11B | 997.00M | 920.00M |
| General and Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling and Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General and Administrative Expenses | 6.89B | 5.98B | 5.19B | 4.52B | 4.29B | 3.79B | 3.93B | 3.56B | 3.28B | 3.08B |
| Other Expenses | 943.00M | 33.00M | 46.00M | 47.00M | 49.00M | 45.00M | 65.00M | 70.00M | 68.00M | 104.00M |
| Operating Expenses | 9.88B | 7.63B | 6.65B | 5.89B | 5.54B | 4.97B | 5.17B | 4.74B | 4.35B | 4.11B |
| Cost and Expenses | 16.10B | 14.11B | 12.06B | 10.86B | 9.97B | 9.31B | 9.02B | 8.09B | 7.52B | 7.15B |
| Net Interest Income | -349.00M | -280.00M | -250.00M | -454.00M | -345.00M | -465.00M | -483.00M | -266.00M | -225.00M | -229.00M |
| Interest Income | 0 | 107.00M | 22.00M | 10.00M | 4.00M | 3.00M | 30.00M | 3.00M | 5.00M | 5.00M |
| Interest Expense | 349.00M | 387.00M | 272.00M | 464.00M | 349.00M | 468.00M | 513.00M | 269.00M | 230.00M | 234.00M |
| Depreciation and Amortization | 0 | 1.27B | 1.20B | 1.14B | 1.09B | 1.12B | 1.01B | 894.00M | 844.00M | 815.00M |
| EBITDA | 3.73B | 3.94B | 3.45B | 2.74B | 2.52B | 1.51B | 2.21B | 2.58B | 2.01B | 1.23B |
| EBIT | 3.73B | 2.67B | 2.26B | 1.60B | 1.43B | 389.00M | 1.20B | 1.69B | 1.16B | 411.00M |
| Non Operating Income Excluding Interest | 238.00M | -34.00M | -76.00M | 219.00M | 497.00M | 212.00M | 512.00M | 46.00M | 362.00M | 825.00M |
| Operating Income | 3.97B | 2.63B | 2.18B | 1.82B | 1.92B | 601.00M | 1.71B | 1.74B | 1.52B | 1.24B |
| Total Other Income Expenses Net | -586.00M | -353.00M | -196.00M | -683.00M | -846.00M | -680.00M | -1.02B | -315.00M | -592.00M | -1.06B |
| Income Before Tax | 3.38B | 2.28B | 1.99B | 1.14B | 1.08B | -79.00M | 687.00M | 1.42B | 933.00M | 177.00M |
| Income Tax Expense | 493.00M | 436.00M | 393.00M | 443.00M | 36.00M | 2.00M | -4.01B | -249.00M | 828.00M | -170.00M |
| Net Income From Continuing Operations | 2.89B | 1.85B | 1.59B | 698.00M | 1.04B | -81.00M | 4.70B | 1.67B | 104.00M | 347.00M |
| Net Income From Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Adjustments To Net Income | 0 | 0 | 0 | 0 | 0 | -1.00M | 0 | 0 | 0 | 0 |
| Net Income | 2.89B | 1.85B | 1.59B | 698.00M | 1.04B | -82.00M | 4.70B | 1.67B | 104.00M | 347.00M |
| Net Income Deductions | 0 | 1.00M | 0 | 1.00M | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrom Line Net Income | — | — | — | — | — | — | — | — | — | — |
| EPS | 1.96 | 1.26 | 1.08 | 0.45 | 0.69 | -0.08 | 3.38 | 1.21 | 0.08 | 0.26 |
| EPS Diluted | 1.94 | 1.25 | 1.07 | 0.45 | 0.69 | -0.08 | 3.33 | 1.19 | 0.07 | 0.25 |
| Weighted Average SHS Out | 1.48B | 1.47B | 1.45B | 1.43B | 1.42B | 1.42B | 1.39B | 1.38B | 1.37B | 1.36B |
| Weighted Average SHS Out Dil | 1.49B | 1.49B | 1.46B | 1.44B | 1.43B | 1.42B | 1.41B | 1.40B | 1.39B | 1.38B |
| Fiscal Year (FMP) | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K |
| Gross Profit Margin | 0.69 | 0.61 | 0.62 | 0.61 | 0.63 | 0.56 | 0.64 | 0.66 | 0.65 | 0.64 |
| R&D to Revenue | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.12 | 0.11 | 0.11 | 0.11 | 0.11 |
| SG&A to Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Burden | 0.91 | 0.86 | 0.88 | 0.71 | 0.76 | -0.2 | 0.57 | 0.84 | 0.8 | 0.43 |
| EBIT Margin | 0.19 | 0.16 | 0.16 | 0.13 | 0.12 | 0.04 | 0.11 | 0.17 | 0.13 | 0.05 |
| EBITDA Margin | 0.19 | 0.24 | 0.24 | 0.22 | 0.21 | 0.15 | 0.21 | 0.26 | 0.22 | 0.15 |
| EBT per EBIT | 0.85 | 0.87 | 0.91 | 0.63 | 0.56 | -0.13 | 0.4 | 0.82 | 0.61 | 0.14 |
| Effective Tax Rate | 0.15 | 0.19 | 0.2 | 0.39 | 0.03 | -0.03 | -5.84 | -0.18 | 0.89 | -0.96 |
| Tax Burden | 0.85 | 0.81 | 0.8 | 0.61 | 0.97 | 1.04 | 6.84 | 1.18 | 0.11 | 1.96 |
| Cont. Operations Profit Margin | 0.14 | 0.11 | 0.11 | 0.06 | 0.09 | -0.01 | 0.44 | 0.17 | 0.01 | 0.04 |
| Bottom Line Profit Margin | 0.14 | 0.11 | 0.11 | 0.05 | 0.08 | -0.01 | 0.44 | 0.17 | 0.01 | 0.04 |
| Operating Cycle | 225.93 | 214.03 | 224.73 | 193.87 | 187.33 | 170.07 | 211.62 | 186.94 | 186.3 | 178.62 |
| Fwd PEG Ratio | 0.88 | 4.27 | 0.37 | -2.69 | -0.06 | 6.07 | 0.07 | 0.02 | -4.72 | -0.35 |
| Earnings Yield | 0.02 | 0.01 | 0.02 | 0.01 | 0.02 | -0 | 0.07 | 0.03 | 0 | 0.01 |
| Income Quality | 1.57 | 1.86 | 1.57 | 2.19 | 1.8 | -18.39 | 0.39 | 0.19 | 13.71 | 2.8 |